Cargando…
Epigenetic dysregulation of ID4 predicts disease progression and treatment outcome in myeloid malignancies
Promoter hypermethylation‐mediated inactivation of ID4 plays a crucial role in the development of solid tumours. This study aimed to investigate ID4 methylation and its clinical relevance in myeloid malignancies. ID4 hypermethylation was associated with higher IPSS scores, but was not an independent...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542913/ https://www.ncbi.nlm.nih.gov/pubmed/28452111 http://dx.doi.org/10.1111/jcmm.13073 |